Latest Trends and Developments in Clinical Trials

About this episode

Kyle Faget and Devin Cohen discuss the current legal and regulatory landscape of clinical trials.

Kyle Faget, Partner, Foley & Lardner LLP, and Devin Cohen, Partner, Proskauer Rose LLP, discuss the current legal and regulatory landscape of clinical trials. They cover issues related to changes to the FDA’s regulatory process, research funding, research misconduct, regulation of wellness products and clinical decision support software, and telehealth and decentralization. Watch this episode: https://www.youtube.com/watch?v=6wz6HgjJTeQ Essential Legal Updates, Now in Audio AHLA's popular...

People in this episode

Guests: Kyle Faget, Devin Cohen

Topics covered

• clinical trials
• legal landscape
• regulatory process
• research funding
• telehealth
• decentralization

Keywords

• clinical trials
• FDA
• regulatory process
• research misconduct
• wellness products
• clinical decision support software
• telehealth

Mentioned in this episode

Organizations: Foley & Lardner LLP, Proskauer Rose LLP, FDA

More episodes of AHLA's Speaking of Health Law

• Navigating Regulatory Pitfalls at the Nexus Between Home Health and Infusion · June 12, 2026 · 28 min
• Managed Care Plans as Critical Partners in Implementing New Medicaid Program Requirements · June 9, 2026 · 34 min
• Leverage LinkedIn and Other Social Media to Amplify Your Thought Leadership · June 5, 2026 · 41 min
• Health Care Corporate Governance: Emerging Trends—Fodder for the Governance Committee · June 2, 2026 · 35 min
• Preparing Health Care Compliance Programs for AI-Driven Enforcement · May 29, 2026 · 46 min
• HIPAA Security Rule Enforcement in 2026: Proposed Changes, Current Expectations, and Risk Management · May 26, 2026 · 27 min